DuPont Reports Second Quarter Results

DuPont (NYSE: DD) today announced financial results for the second quarter of 2019 and raised its full year guidance for pro forma adjusted EPS[1] to a range of $3.75 to $3.85.   

“In the face of weaker than expected market conditions, our teams delivered on our bottom-line commitments by driving both cost and pricing actions resulting in operating EBITDA[1] margin improvement of 170 basis points in the quarter,” said Marc Doyle, DuPont Chief Executive Officer.

“We also improved gross margin by more than 200 basis points with gains in each of our core segments,” Doyle continued.  “We delivered these results by continuing to realize the benefits from our cost synergy initiatives, enacting new productivity programs in the face of challenged end markets, and driving higher pricing based on the value-added solutions we deliver.

We saw strength in probiotics, water, safety, aerospace and healthcare end markets where we were able to capitalize on our strong customer relationships and innovative solutions.  However, our portfolio is diverse, and our top-line results were impacted by the on-going softness in our short-cycle businesses.”

You can view the entire DuPont second quarter earnings release at:  Click here.

[1] Adjusted EPS, pro forma adjusted EPS, operating EBITDA and pro forma operating EBITDA are non-GAAP measures.  See page 8 for further discussion.

If you would rather not receive future communications from E.I. du Pont de Nemours and Company, Inc, let us know by clicking here.
E.I. du Pont de Nemours and Company, Inc, 974 Centre Road, Wilmington, DE 19805 United States
This communication is for use by the intended recipient and contains information that may be Privileged, confidential or copyrighted under applicable law. If you are not the intended recipient, you are hereby formally notified that any use, copying or distribution of this e-mail, in whole or in part, is strictly prohibited. Please notify the sender by return e-mail and delete this e-mail from your system. Unless explicitly and conspicuously designated as "E-Contract Intended", this e-mail does not constitute a contract offer, a contract amendment, or an acceptance of a contract offer. This e-mail does not constitute a consent to the use of sender's contact information for direct marketing purposes or for transfers of data to third parties.